ADALIMUMAB-ADAZ(CF) PEN 40 MG/0.4 ML

adalimumab-adaz
$1592.1600per ML

Strength

40 mg/.4mL

Manufacturer

Sandoz Inc.

NDC

61314032720

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

4/22/2026

Active Ingredients

ADALIMUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA761071

On Market Since

7/1/2023

Pharmacological Classes

Antibodies
Monoclonal
Tumor Necrosis Factor Blocker
Tumor Necrosis Factor Receptor Blocking Activity

Price History

1W

0.0%

1M

-0.1%

3M

-0.1%

6M

+0.0%

1Y

+0.2%

3Y

N/A

5Y

N/A

All

-0.0%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

No related drugs found.